Whole-exome sequencing with targeted analysis and epilepsy after acute symptomatic neonatal seizures
- PMID: 33846556
- PMCID: PMC9064802
- DOI: 10.1038/s41390-021-01509-3
Whole-exome sequencing with targeted analysis and epilepsy after acute symptomatic neonatal seizures
Abstract
Background: The contribution of pathogenic gene variants with development of epilepsy after acute symptomatic neonatal seizures is not known.
Methods: Case-control study of 20 trios in children with a history of acute symptomatic neonatal seizures: 10 with and 10 without post-neonatal epilepsy. We performed whole-exome sequencing (WES) and identified pathogenic de novo, transmitted, and non-transmitted variants from established and candidate epilepsy association genes and correlated prevalence of these variants with epilepsy outcomes. We performed a sensitivity analysis with genes associated with coronary artery disease (CAD). We analyzed variants throughout the exome to evaluate for differential enrichment of functional properties using exploratory KEGG searches.
Results: Querying 200 established and candidate epilepsy genes, pathogenic variants were identified in 5 children with post-neonatal epilepsy yet in only 1 child without subsequent epilepsy. There was no difference in the number of trios with non-transmitted pathogenic variants in epilepsy or CAD genes. An exploratory KEGG analysis demonstrated a relative enrichment in cell death pathways in children without subsequent epilepsy.
Conclusions: In this pilot study, children with epilepsy after acute symptomatic neonatal seizures had a higher prevalence of coding variants with a targeted epilepsy gene sequencing analysis compared to those patients without subsequent epilepsy.
Impact: We performed whole-exome sequencing (WES) in 20 trios, including 10 children with epilepsy and 10 without epilepsy, both after acute symptomatic neonatal seizures. Children with post-neonatal epilepsy had a higher burden of pathogenic variants in epilepsy-associated genes compared to those without post-neonatal epilepsy. Future studies evaluating this association may lead to a better understanding of the risk of epilepsy after acute symptomatic neonatal seizures and elucidate molecular pathways that are dysregulated after brain injury and implicated in epileptogenesis.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Garfinkle J, Shevell MI. Cerebral palsy, developmental delay, and epilepsy after neonatal seizures. Pediatr. Neurol. 2011;44:88–96. - PubMed
-
- Nunes ML, et al. Neurological outcomes of newborns with neonatal seizures. Arq. Neuropsiquiatr. 2008;66:168–174. - PubMed
-
- Ronen GM, Buckley D, Penney S, Streiner DL. Long-term prognosis in children with neonatal seizures: a population based study. Neurology. 2007;69:1816–1822. - PubMed
-
- Pisani F, et al. Neonatal seizures and postneonatal epilepsy: a 7-y follow-up study. Pediatr. Res. 2012;72:186–193. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous